Your prediction
Protalix Biotherapeutics Inc. Stock
There is an upward development for Protalix Biotherapeutics Inc. compared to yesterday, with an increase of €0.020 (1.150%).
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 1.150% | 14.474% | 16.000% | -19.032% | 13.725% | 18.367% | -42.384% |
| Compugen Ltd. | -3.890% | 27.327% | 23.977% | 10.417% | 28.875% | 74.845% | - |
| Chromadex Corp | -1.800% | -6.087% | -2.703% | 6.931% | -1.818% | 172.315% | 43.617% |
| Intellia Therapeutics Inc | 3.170% | 20.892% | 31.113% | 2.502% | 29.131% | -70.980% | -83.893% |
